243 related articles for article (PubMed ID: 25339409)
1. Evaluation of the efficacy of outer membrane protein 31 vaccine formulations for protection against Brucella canis in BALB/c mice.
Clausse M; Díaz AG; Ibañez AE; Cassataro J; Giambartolomei GH; Estein SM
Clin Vaccine Immunol; 2014 Dec; 21(12):1689-94. PubMed ID: 25339409
[TBL] [Abstract][Full Text] [Related]
2. Improved immunogenicity of a vaccination regimen combining a DNA vaccine encoding Brucella melitensis outer membrane protein 31 (Omp31) and recombinant Omp31 boosting.
Cassataro J; Velikovsky CA; Bruno L; Estein SM; de la Barrera S; Bowden R; Fossati CA; Giambartolomei GH
Clin Vaccine Immunol; 2007 Jul; 14(7):869-74. PubMed ID: 17428946
[TBL] [Abstract][Full Text] [Related]
3. Vaccination with the recombinant Brucella outer membrane protein 31 or a derived 27-amino-acid synthetic peptide elicits a CD4+ T helper 1 response that protects against Brucella melitensis infection.
Cassataro J; Estein SM; Pasquevich KA; Velikovsky CA; de la Barrera S; Bowden R; Fossati CA; Giambartolomei GH
Infect Immun; 2005 Dec; 73(12):8079-88. PubMed ID: 16299302
[TBL] [Abstract][Full Text] [Related]
4. The vaccine candidate BLSOmp31 protects mice against Brucella canis infection.
Clausse M; Díaz AG; Ghersi G; Zylberman V; Cassataro J; Giambartolomei GH; Goldbaum FA; Estein SM
Vaccine; 2013 Dec; 31(51):6129-35. PubMed ID: 23906889
[TBL] [Abstract][Full Text] [Related]
5. Immunization with recombinant Brucella species outer membrane protein Omp16 or Omp19 in adjuvant induces specific CD4+ and CD8+ T cells as well as systemic and oral protection against Brucella abortus infection.
Pasquevich KA; Estein SM; García Samartino C; Zwerdling A; Coria LM; Barrionuevo P; Fossati CA; Giambartolomei GH; Cassataro J
Infect Immun; 2009 Jan; 77(1):436-45. PubMed ID: 18981242
[TBL] [Abstract][Full Text] [Related]
6. A DNA vaccine coding for the Brucella outer membrane protein 31 confers protection against B. melitensis and B. ovis infection by eliciting a specific cytotoxic response.
Cassataro J; Velikovsky CA; de la Barrera S; Estein SM; Bruno L; Bowden R; Pasquevich KA; Fossati CA; Giambartolomei GH
Infect Immun; 2005 Oct; 73(10):6537-46. PubMed ID: 16177328
[TBL] [Abstract][Full Text] [Related]
7. A recombinant subunit vaccine based on the insertion of 27 amino acids from Omp31 to the N-terminus of BLS induced a similar degree of protection against B. ovis than Rev.1 vaccination.
Cassataro J; Pasquevich KA; Estein SM; Laplagne DA; Velikovsky CA; de la Barrera S; Bowden R; Fossati CA; Giambartolomei GH; Goldbaum FA
Vaccine; 2007 May; 25(22):4437-46. PubMed ID: 17442465
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the Efficacy of the Brucella canis RM6/66 Δ
Stranahan LW; Chaki SP; Garcia-Gonzalez DG; Khalaf OH; Arenas-Gamboa AM
mSphere; 2020 May; 5(3):. PubMed ID: 32434839
[No Abstract] [Full Text] [Related]
9. Improved immunogenicity and protective efficacy of a divalent DNA vaccine encoding Brucella L7/L12-truncated Omp31 fusion protein by a DNA priming and protein boosting regimen.
Golshani M; Rafati S; Siadat SD; Nejati-Moheimani M; Shahcheraghi F; Arsang A; Bouzari S
Mol Immunol; 2015 Aug; 66(2):384-91. PubMed ID: 25968974
[TBL] [Abstract][Full Text] [Related]
10. Immunization of mice with a novel recombinant molecular chaperon confers protection against Brucella melitensis infection.
Ghasemi A; Jeddi-Tehrani M; Mautner J; Salari MH; Zarnani AH
Vaccine; 2014 Nov; 32(49):6659-66. PubMed ID: 25240754
[TBL] [Abstract][Full Text] [Related]
11. Vaccination with recombinant L7/L12-truncated Omp31 protein induces protection against Brucella infection in BALB/c mice.
Golshani M; Rafati S; Dashti A; Gholami E; Siadat SD; Oloomi M; Jafari A; Bouzari S
Mol Immunol; 2015 Jun; 65(2):287-92. PubMed ID: 25723468
[TBL] [Abstract][Full Text] [Related]
12. Oral immunization of mice with Omp31-loaded
Abkar M; Fasihi-Ramandi M; Kooshki H; Sahebghadam Lotfi A
Int J Nanomedicine; 2017; 12():8769-8778. PubMed ID: 29263667
[TBL] [Abstract][Full Text] [Related]
13. Simultaneous immunization of mice with Omp31 and TF provides protection against Brucella melitensis infection.
Ghasemi A; Jeddi-Tehrani M; Mautner J; Salari MH; Zarnani AH
Vaccine; 2015 Oct; 33(42):5532-5538. PubMed ID: 26384448
[TBL] [Abstract][Full Text] [Related]
14. Recombinant outer membrane protein 25c from Brucella abortus induces Th1 and Th2 mediated protection against Brucella abortus infection in mouse model.
Paul S; Peddayelachagiri BV; Nagaraj S; Kingston JJ; Batra HV
Mol Immunol; 2018 Jul; 99():9-18. PubMed ID: 29649688
[TBL] [Abstract][Full Text] [Related]
15. The polymeric antigen BLSOmp31 confers protection against Brucella ovis infection in rams.
Estein SM; Fiorentino MA; Paolicchi FA; Clausse M; Manazza J; Cassataro J; Giambartolomei GH; Coria LM; Zylberman V; Fossati CA; Kjeken R; Goldbaum FA
Vaccine; 2009 Nov; 27(48):6704-11. PubMed ID: 19748579
[TBL] [Abstract][Full Text] [Related]
16. The recombinant Omp31 from Brucella melitensis alone or associated with rough lipopolysaccharide induces protection against Brucella ovis infection in BALB/c mice.
Estein SM; Cassataro J; Vizcaíno N; Zygmunt MS; Cloeckaert A; Bowden RA
Microbes Infect; 2003 Feb; 5(2):85-93. PubMed ID: 12650766
[TBL] [Abstract][Full Text] [Related]
17. Vaccination with Brucella recombinant DnaK and SurA proteins induces protection against Brucella abortus infection in BALB/c mice.
Delpino MV; Estein SM; Fossati CA; Baldi PC; Cassataro J
Vaccine; 2007 Sep; 25(37-38):6721-9. PubMed ID: 17686554
[TBL] [Abstract][Full Text] [Related]
18. Immunization with Brucella VirB proteins reduces organ colonization in mice through a Th1-type immune response and elicits a similar immune response in dogs.
Pollak CN; Wanke MM; Estein SM; Delpino MV; Monachesi NE; Comercio EA; Fossati CA; Baldi PC
Clin Vaccine Immunol; 2015 Mar; 22(3):274-81. PubMed ID: 25540276
[TBL] [Abstract][Full Text] [Related]
19. Protection of BALB/c mice against Brucella abortus 544 challenge by vaccination with bacterioferritin or P39 recombinant proteins with CpG oligodeoxynucleotides as adjuvant.
Al-Mariri A; Tibor A; Mertens P; De Bolle X; Michel P; Godefroid J; Walravens K; Letesson JJ
Infect Immun; 2001 Aug; 69(8):4816-22. PubMed ID: 11447155
[TBL] [Abstract][Full Text] [Related]
20. In vivo immunogenicity assessment and vaccine efficacy evaluation of a chimeric tandem repeat of epitopic region of OMP31 antigen fused to interleukin 2 (IL-2) against Brucella melitensis in BALB/c mice.
Nazifi N; Tahmoorespur M; Sekhavati MH; Haghparast A; Behroozikhah AM
BMC Vet Res; 2019 Nov; 15(1):402. PubMed ID: 31703683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
